£
Donate
Donate

Give a major gift to Trial Treat Beat

Trial Treat Beat is our £25 million mission to double survival chances for people with the deadliest blood cancers. A major gift of £5,000 or more helps fund the clinical trials that make this possible.

Too many people are dying of blood cancer.

Right now, only 1 in 3 people with the deadliest blood cancers will survive. Even more shockingly, we lose them in the first five years after diagnosis. We're determined to change this.

Too many people are dying from the most complex and aggressive forms of blood cancer. Myelomas, high grade lymphomas and myeloid cancers including acute myeloid leukaemia are the deadliest blood cancers and account for half of all blood cancer deaths.

We're determined to change the odds and save more lives

We've launched Trial Treat Beat; a £25 million mission to double survival chances for people with the deadliest blood cancers.

The work we do is only possible because of generous supporters like you. A gift of £5,000 or more allows us to invest significantly in our Trial Treat Beat clinical trials and services, and there are many ways you can support Trial Treat Beat.

Ways to support Trial Treat Beat

  • Make a personal donation

  • Give through a trust or foundation

  • Become a corporate partner

  • Give through your donor advised fund

  • Donate your shares

£24 million for three large scale, innovative clinical trials

Traditional clinical trials test one treatment at a time. If it fails, researchers start again from scratch. Trial Treat Beat will enable us to fund three innovative, large-scale clinical trials, including multi-arm, multi-stage studies (MAMS) that will each test several treatment approaches – making them faster and more efficient.

If a treatment isn't working, we drop it and add a new one. When promising therapies emerge, we test them immediately. This means that we can develop personalised treatments at a much faster pace for the hardest to treat blood cancers.

£1 million to reach every person who needs us

Research discoveries only matter if patients can benefit from them. The final £1m will help clinical trials breakthroughs reach everyone who needs them. We'll invest in our Clinical Trials Navigation Service to help people find clinical trials that could benefit them, and in our policy work so that we ensure that everyone with blood cancer has fair access to treatments when they’re available.

Why your support matters

What your support means to people affected by blood cancer.

Person wearing glasses and a light blue shirt, with a closely shaved head and a small rainbow-colored earring, photographed indoors against a botanical-patterned wall

Kate's multiple myeloma journey began long before she ever heard the words "blood cancer.”

She pushed for further treatment and asked about clinical trials.

"New treatments are coming out all the time. Two have already come out since I was diagnosed. The more we push for research, the longer we can live."

Kate, diagnosed with multiple myeloma

A patient in a hospital chair holds hands with a visitor, beside medical monitors.

Moonii was diagnosed with AML in 2002. He’s now a trustee for several charities, raising funds for those facing terminal diagnoses and supporting patients like himself.

"My doctors asked to use my blood for genome therapy research. I said, '100% - anything to help find a cure for blood cancer like AML.' Cures only come through trials, and I want to be a part of that."

Moonii, diagnosed with AML

Make a transformative gift

£12.4m raised of £25m goal 51% to go

Every donation brings us closer to funding the trials that will help double survival chances.

Email the Philanthropy team

Celebrating your support

As a supporter, you'll see the impact of your gift unfold - through private invitations to lab tours, milestone updates, and access to the researchers working to save lives.

If you donate a gift of £50,000 or more to the appeal, we offer the following naming opportunities:

  • Transformational Partner: £4m+

  • Founding Partner: £1m+

  • Principal Supporter: £500,000+

  • Major Partner: £100,000 - £500,000

  • Supporter: £50,000 - £100,000

Our transformational partner Omaze

We're proud to work alongside our transformational partner Omaze to deliver the first clinical trial for Trial Treat Beat. Their support helps us increase awareness of clinical trials, fund vital research, and improve outcomes for people affected by blood cancer.

Your gift funds the trial that gives someone their next year.

Trial Treat Beat funds the specific clinical trials that get new treatments into patients today.

To find out more about giving a larger gift, or to discuss the impact of your donation, please contact the philanthropy team today: [email protected]

Get in touch

To find out more about giving a major gift to Trial Treat Beat and our commitment to beating all blood cancers, contact our Philanthropy team at [email protected] or call 0808 2080 888.